Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$38.88 - $45.31 $155 - $181
-4 Reduced 0.03%
15,880 $700,000
Q2 2021

Aug 17, 2021

BUY
$36.52 - $41.46 $146 - $165
4 Added 0.03%
15,884 $632,000
Q1 2021

May 14, 2021

SELL
$34.27 - $40.01 $815,763 - $952,398
-23,804 Reduced 59.98%
15,880 $567,000
Q4 2020

Feb 12, 2021

SELL
$34.07 - $39.94 $49,333 - $57,833
-1,448 Reduced 3.52%
39,684 $1.46 Million
Q3 2020

Nov 13, 2020

BUY
$38.11 - $42.99 $55,450 - $62,550
1,455 Added 3.67%
41,132 $1.55 Million
Q2 2020

Aug 14, 2020

BUY
$37.87 - $43.58 $37,567 - $43,231
992 Added 2.56%
39,677 $1.62 Million
Q1 2020

May 14, 2020

SELL
$32.47 - $48.83 $25,066 - $37,696
-772 Reduced 1.96%
38,685 $1.47 Million
Q4 2019

Feb 10, 2020

BUY
$42.0 - $48.25 $11,928 - $13,703
284 Added 0.72%
39,457 $1.85 Million
Q3 2019

Nov 14, 2019

BUY
$40.46 - $43.52 $100,219 - $107,799
2,477 Added 6.75%
39,173 $1.67 Million
Q2 2019

Jul 24, 2019

BUY
$39.4 - $42.7 $30,495 - $33,049
774 Added 2.15%
36,696 $1.47 Million
Q1 2019

May 15, 2019

SELL
$38.57 - $42.69 $72,820 - $80,598
-1,888 Reduced 4.99%
35,922 $1.5 Million
Q4 2018

Feb 14, 2019

BUY
$37.8 - $42.69 $2,268 - $2,561
60 Added 0.16%
37,810 $1.44 Million
Q3 2018

Nov 13, 2018

SELL
$39.75 - $42.69 $26,076 - $28,004
-656 Reduced 1.71%
37,750 $1.52 Million
Q2 2018

Aug 14, 2018

BUY
$39.61 - $42.76 $31,450 - $33,951
794 Added 2.11%
38,406 $1.55 Million
Q1 2018

May 14, 2018

BUY
$36.18 - $40.15 $205,140 - $227,650
5,670 Added 17.75%
37,612 $1.47 Million
Q4 2017

Feb 12, 2018

SELL
$35.34 - $41.9 $371,635 - $440,620
-10,516 Reduced 24.77%
31,942 $1.13 Million
Q3 2017

Nov 14, 2017

BUY
$39.44 - $41.55 $82,863 - $87,296
2,101 Added 5.21%
42,458 $1.72 Million
Q2 2017

Aug 14, 2017

BUY
N/A
40,357
40,357 $1.74 Million

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Logan Capital Management Inc Portfolio

Follow Logan Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logan Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Logan Capital Management Inc with notifications on news.